STI/HIV Unit, San Gallicano Dermatological Institute IRCCS, Rome, Italy.
Eur Rev Med Pharmacol Sci. 2022 May;26(10):3407. doi: 10.26355/eurrev_202205_28832.
Correction to: European Review for Medical and Pharmacological Sciences 2022; 26 (7): 2631-2638-DOI: 10.26355/eurrev_202204_28501-PMID: 35442479, published online on 15 April 2022. After publication, at the request of the Italian Ministry of Health, the authors asked to insert the following statement in the Acknowledgments section: "This research was funded by the Italian Ministry of Health (RC 2022)". There are amendments to this paper. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/28501.
欧洲医学与药物科学评论 2022 年;26(7):2631-2638-DOI:10.26355/eurrev_202204_28501-PMID:35442479,在线发表于 2022 年 4 月 15 日。发表后,应意大利卫生部的要求,作者要求在致谢部分插入以下声明:“本研究由意大利卫生部(RC 2022)资助”。本文有修订。出版商对由此造成的任何不便表示歉意。https://www.europeanreview.org/article/28501.